Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

M Thompson, Ian; M Tangen, Catherine; Paradelo, Jorge; Scott Lucia, M; Miller, Gary; Troyer, Dean; Messing, Edward; Forman, Jeffrey; Chin, Joseph; Swanson, Gregory; Canby-Hagino, Edith; David Crawford, E

doi:10.1016/j.juro.2008.11.032

Public

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Shared by NobleBlocks on Mar 1, 2009 • 12:00 AM UTC

Authors:

Ian M Thompson

Catherine M Tangen

Jorge Paradelo

Abstract

PURPOSE: Extraprostatic disease will be manifest in a third of men after radical prostatectomy. We present the long-term followup of a randomized clinical trial of radiotherapy to reduce the risk of subsequent metastatic disease and death. MATERIALS AND METHODS: A total of 431 men with pT3N0M0 prost...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!